Sales to outside customers increased significantly to 18,565 million yen
(up 11.5% year-on-year).
Hydrox Laboratories, which manufactures and sells medical disinfectants
and other products, continued to perform strongly and made a significant
contribution to the increase in sales.
Segment profit (operating profit basis) increased significantly to 1,205
million yen (up 66.5% year-on-year) owing to a significant increase in
sales and improvement of the cost of sales ratio, as well as efficient
utilization of selling, general and administrative expenses.